Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.2K Buy
34,911
+3,965
+13% +$50.9K ﹤0.01% 7439
2026
Q1
$72.4K Buy
30,946
+16,996
+122% +$83.8K ﹤0.01% 7162
2025
Q4
$114K Buy
13,950
+13,949
+1,394,900% +$241K ﹤0.01% 6843
2025
Q3
$25 Sell
1
-1,504
-100% -$53.2K ﹤0.01% 10109
2025
Q2
$86.1K Buy
1,505
+324
+27% +$20.2K ﹤0.01% 7358
2025
Q1
$101K Buy
1,181
+139
+13% +$13.1K ﹤0.01% 7039
2024
Q4
$120K Buy
+1,042
New +$118K ﹤0.01% 6758
2024
Q3
Sell
-35
Closed -$3.83K 9460
2024
Q2
$3.83K Buy
+35
New +$7.35K ﹤0.01% 8169
2023
Q4
Sell
-1
Closed -$213 9248
2023
Q3
$213 Sell
1
-1
-50% -$809 ﹤0.01% 8690
2023
Q2
$1.96K Buy
+2
New +$2.04K ﹤0.01% 7828
2023
Q1
Hold
0
8972

Other funds holding AIXI

UBS Group's AIXI Position: Q2 2026 in Review

UBS Group increased its Xiao-I (AIXI) stake by 13% in Q2 2026, buying an estimated $50.9K and bringing the position to 34,911 shares worth $64.2K. The position accounts for ﹤0.01% of the portfolio, ranked #7439.

UBS Group first reported a position in AIXI in Q2 2023 and has held it in 10 quarters since. The position peaked at $120K in Q4 2024. 5 funds tracked by Wall St. Rank hold AIXI as of Q2 2026.

  • UBS Group held 34,911 shares of Xiao-I worth $64.2K as of Q2 2026.
  • UBS Group bought 3,965 Xiao-I shares in Q2 2026, an estimated $50.9K.
  • Xiao-I made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7439 holding.
  • UBS Group first reported a position in Xiao-I in Q2 2023 and has held it in 10 quarters since.
  • UBS Group's Xiao-I position peaked at $120K in Q4 2024.
  • 5 funds tracked by Wall St. Rank held Xiao-I as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.